Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Three Commercial Batches of Japanese Encephalitis Vaccine IC51
2007-002771-14Phase 3Completed
- Sponsor
- Intercell AG
- Start
- Sep 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of japanese encephalitis vaccine (inactivated, adsorbed) in Japanese encephalitis (JE) (3 arms), sponsored by Intercell AG. Started Sep 2007; status: completed.
02
Drugs
japanese encephalitis vaccine (inactivated, adsorbed)
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on 2007-002771-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002771-14.